Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2012
06/20/2012CN102499938A Agonist and application of Toll-like receptors 7 and 8
06/20/2012CN102499936A Compound telithromycin nanoemulsion oral liquid and preparation method thereof
06/20/2012CN102499935A Compound spiramycin nanoemulsion oral liquid and preparation method thereof
06/20/2012CN102499931A New application of disaccharide compound
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102499928A Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid
06/20/2012CN102499922A Cefmenoxime hydrochloride composition for injection and preparation thereof
06/20/2012CN102499912A Garlic extract and preparation method thereof as well as application in preparation of drugs for resisting HIV-1 virus, tubercle bacillus and Toxoplasma gondii
06/20/2012CN102499911A Tea saponine nanocapsule, preparation method and application thereof
06/20/2012CN102499909A Itraconazole dispersible tablets and preparation method thereof
06/20/2012CN102499541A Red bayberry health-care cushion
06/20/2012CN102499243A Biological disinfectant
06/20/2012CN102166238B Notoginseng extract and application thereof
06/20/2012CN102091127B New technology for extracting Chinese magnoliavine fruit lignanoid
06/20/2012CN102058559B Doxycycline hydrochloride effervescent tables for milk cows and preparation method thereof
06/20/2012CN102028715B Method for extracting total flavonoids from plants
06/20/2012CN102018669B Long-acting ceftiofur hydrochloride injection and preparation method thereof
06/20/2012CN102002499B shRNA capable of inhibiting replication and infection of Japanese encephalitis virus and application thereof
06/20/2012CN101988067B Prion isomer monoclonal antibody gene and application thereof
06/20/2012CN101918014B Medicinal composition
06/20/2012CN101904839B Application of imperatorin in preparing medicament for preventing and treating hepatitis or liver injury
06/20/2012CN101904823B Thiamphenicol glycinate hydrochloride freeze-dried powder injection and preparation method thereof
06/20/2012CN101874818B Medicament or health-care product composition for reducing blood pressure or blood fat and preparation method and application thereof
06/20/2012CN101862452B Method for preparing swine multi-valent antiserum compound preparation
06/20/2012CN101850115B Method for producing swine fever live vaccine by using porcine kidney cell line (IBRS-2) and product thereof
06/20/2012CN101822650B Minocycline hydrochloride sustained release tablet and preparation method thereof
06/20/2012CN101798568B Separated vibrio parahaemolyticus phage and applications in sterilization and microbe-proofing thereof
06/20/2012CN101787025B Substituted-evodiamine anti-tumor and antifungal compounds and preparation method thereof
06/20/2012CN101732339B Foot odor preventing medical powder
06/20/2012CN101724023B Restricted epitope peptide of antigen of mycobacterium tuberculosis
06/20/2012CN101723957B Method for preparing ampicillin sodium salt
06/20/2012CN101716277B Method for determining active ingredients of rhizoma smilacis glabrae medicinal material
06/20/2012CN101670010B Method for extracting flavonoid glycoside substance
06/20/2012CN101659676B Sulfo-Adefovir and Tenofovir liver targeting ester prodrug
06/20/2012CN101643501B Novel antibiotic and nucleotide sequence, preparation method and application thereof
06/20/2012CN101454010B Antifungal agents
06/20/2012CN101422556B Exterior-applied medicine for treating dermatopathy
06/20/2012CN101297655B Compound formulation for killing bacillus spore
06/20/2012CN101289483B Macrolides with antibacterial activity
06/20/2012CN101233147B Macrocyclic inhibitors of hepatitis c virus
06/20/2012CN101072793B Il-7 variants with reduced immunogenicity
06/19/2012US8202980 Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference
06/19/2012US8202846 Methods and compositions for RNA interference
06/19/2012CA2733145C Aztreonam l-lysine and method of determining impurities therein
06/19/2012CA2683939C Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
06/19/2012CA2607151C Hiv integrase inhibitors
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
06/19/2012CA2471043C Stable surfactant compositions for suspending components
06/19/2012CA2406169C Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/19/2012CA2349202C Method of preparing stable suspensions of insoluble microparticles
06/14/2012WO2012079035A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
06/14/2012WO2012079032A2 Compositions and methods of treating drug-resistant retroviral infections
06/14/2012WO2012078915A1 Macrocyclic inhibitors of flaviviridae viruses
06/14/2012WO2012078844A1 Hiv integrase inhibitors
06/14/2012WO2012078834A1 Hiv integrase inhibitors
06/14/2012WO2012078637A2 Composition and method for oligonucleotide delivery
06/14/2012WO2012078559A2 Small-molecule hydrophobic tagging of fusion proteins and induced degradation of same
06/14/2012WO2012078545A1 Benzofurane derivatives for the treatment of hepatitits c
06/14/2012WO2012078416A2 Monophosphate prodrugs of dapd and analogs thereof
06/14/2012WO2012078121A2 Solid oral dosage form comprising cefdinir
06/14/2012WO2012078070A1 Fungicide
06/14/2012WO2012077849A1 Antimicrobial peptide multiblock copolymer to be expressed on surface of cells
06/14/2012WO2012077828A1 Therapeutic agent for inflammatory diseases, which can inhibit function of inflammatory cytokine
06/14/2012WO2012077811A1 Galectin 9-secreting cell, production method for same, and application for same
06/14/2012WO2012076934A1 Glycomimetic compounds as anti-infectious against pathogens lectins
06/14/2012WO2012076868A1 Antibodies to mycobacteria
06/14/2012WO2012076832A1 Suppositories comprising rifaximin
06/14/2012WO2012076718A1 Anti-microbial composition
06/14/2012WO2012076717A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
06/14/2012WO2012076323A1 Oligosaccharide composition for treating acute respiratory tract infections
06/14/2012WO2012076016A1 Process for the manufacture of ajoene derivatives
06/14/2012WO2012075927A1 Thiazolamine derivative and use thereof as anti-picornaviral infection medicament
06/14/2012WO2012075908A1 Use of quinazoline compound in preparation of anti-flavivirus drug
06/14/2012WO2012075744A1 Pharmaceutical composition comprising pyrazolopyrimidinone-like compound
06/14/2012WO2012075684A1 Lactobacillus strains and use thereof for regulating immune response
06/14/2012WO2012075646A1 Traditional chinese medicine composition for treating infection of influenza a virus subtype and preparation method thereof
06/14/2012WO2012051988A3 Derivatives of steroid benzylamines, having an antiparasitic, antibacterial, antimycotic and/or antiviral action
06/14/2012WO2012048013A3 Phosphorodiamidate derivatives of guanosine nucleoside compounds for treatment of viral injections
06/14/2012WO2012035310A3 Therapeutic conjugates of a dextrin polymer and an antimicrobial peptide
06/14/2012WO2012033911A3 Polyionic papilloma virus-like particle (vlp) vaccines
06/14/2012WO2011139385A3 Genetic signatures in hiv-1 subtype c envelope glycoproteins
06/14/2012WO2011050384A9 Pharmaceutical composition for the treatment and prevention of a rhinovirus infection
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149785 Method of estimating sepsis risk in an individual with infection
06/14/2012US20120149783 Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
06/14/2012US20120149778 Compounds
06/14/2012US20120149771 Method for treating airway hyper-responsiveness with lipoxin analogs
06/14/2012US20120149751 Antiviral Drugs for Treatment of Arenavirus Infection
06/14/2012US20120149748 Pharmaceutical Cream Compositions and Methods of Use
06/14/2012US20120149745 Antimycotic pharmaceutical composition
06/14/2012US20120149733 Piperidinyl compound as a modulator of chemokine receptor activity
06/14/2012US20120149732 Multifunctional linkers and methods for the use thereof
06/14/2012US20120149729 Metalloenzyme inhibitor compounds
06/14/2012US20120149720 Valacyclovir formulations
06/14/2012US20120149716 Methods of using and compositions comprising pde4 modulators for treatment, prevention and management of tuberculosis
06/14/2012US20120149715 Compounds and methods for the treatment of viral infections
06/14/2012US20120149710 Sortase a inhibitors
06/14/2012US20120149708 Modulators of viral transcription, and methods and compositions therewith
06/14/2012US20120149702 Inhibitors of cellular necrosis
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 1798